340B Transparency Act

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 3290 Introduced in House (IH)] <DOC> 118th CONGRESS 1st Session H. R. 3290 To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES May 15, 2023 Mr. Bucshon introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. ENSURING TRANSPARENCY AND OVERSIGHT OF THE 340B DRUG DISCOUNT PROGRAM. (a) In General.--Section 340B(a)(5) of the Public Health Service Act (42 U.S.C. 256b(a)(5)) is amended-- (1) in subparagraph (C)-- (A) by striking ``A covered entity shall permit'' and inserting: ``(i) Duplicate discounts and drug resale.--A covered entity shall permit''; and (B) by adding …